Historical Stock Price
ZLCS historical stock prices picture
ZLCS (ZLCS) has the following price history information. Looking back at ZLCS historical stock prices for the last five trading days, on July 09, 2014, ZLCS opened at $1.18, traded as high as $1.22 and as low as $1.17, and closed at $1.18. Trading volume was a total of 266.40K shares. On July 10, 2014, ZLCS opened at $1.16, traded as high as $1.18 and as low as $1.15, and closed at $1.16. Trading volume was a total of 93.80K shares. On July 11, 2014, ZLCS opened at $1.17, traded as high as $1.18 and as low as $1.13, and closed at $1.14. Trading volume was a total of 121.60K shares. On July 14, 2014, ZLCS opened at $1.16, traded as high as $1.17 and as low as $1.14, and closed at $1.15. Trading volume was a total of 104.60K shares. On July 15, 2014, ZLCS opened at $1.15, traded as high as $1.29 and as low as $1.13, and closed at $1.18. Trading volume was a total of 1.16M shares.

ZLCS Historical Stock Prices By Date:

ZLCS historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ZLCS shares, starting with a $10,000 purchase of ZLCS, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/01/2014
End date: 07/15/2014
Start price/share: $1.23
End price/share: $1.18
Dividends collected/share: $0.00
Total return: -4.07%
Annualized Gain: -14.13%
Starting investment: $10,000.00
Ending investment: $9,593.00
Years: 0.29
Date Open High Low Close Volume
07/09/2014 $1.18 $1.22 $1.17 $1.18 266.40K
07/10/2014 $1.16 $1.18 $1.15 $1.16 93.80K
07/11/2014 $1.17 $1.18 $1.13 $1.14 121.60K
07/14/2014 $1.16 $1.17 $1.14 $1.15 104.60K
07/15/2014 $1.15 $1.29 $1.13 $1.18 1.16M
Zalicus is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain. Co.'s primary product candidate is Z160, an oral N-type calcium channel blocker that Co. is seeking to develop for the treatment of chronic pain. Co.'s other product candidate is Z944, an oral T-type calcium channel blocker that Co. is seeking to develop for the treatment of pain indications. In addition, Co. is performing discovery research and preclinical development activities on its proprietary selective ion channel modulators targeting the Nav1.7 sodium channel as well as N-type and T-type calcium channels, as part of a research collaboration with Hydra Biosciences, Inc.
Date Close
07/09/2014$1.18
07/10/2014$1.16
07/11/2014$1.14
07/14/2014$1.15
07/15/2014$1.18
ZLCS is categorized under the Healthcare sector; below are some other companies in the same sector:

ZLTQ Historical Stock Prices
ZMH Historical Stock Prices
ZSAN Historical Stock Prices
ZSPH Historical Stock Prices
ZTS Historical Stock Prices
ZYNE Historical Stock Prices
A Historical Stock Prices
AAC Historical Stock Prices
AAVL Historical Stock Prices
ABAX Historical Stock Prices

Email EnvelopeFree ZLCS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


ZLCS Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.